Drug Transparency Act (Apr. 2019)

The goal of the Drug Transparency Act (“the Braun Bill”) is to encourage pharmacy benefit managers to pass discounts from drug manufacturers directly to consumers and bring transparency to the prescription drug market. It would prohibit pharmacy benefit managers from receiving any rebates or reductions in price from drug manufacturers, and would require any rebates […]
This content is only available to members. Learn more about membership here or login.